-
Write A Prescription For More Pharma M&A With This ETF
Wednesday, August 24, 2016 - 10:00am | 583Read More...Pfizer Inc. (NYSE: PFE) revealed Monday it is acquiring Medivation Inc (NASDAQ: MDVN), which has plenty of market participants speculating as to which companies could be the next takeover targets in the pharmaceuticals space. A Pharma ETF Of course, there are exchange-traded funds with which to...
-
Pfizer Has Had A Busy M&A Year...Or Has It?
Tuesday, August 23, 2016 - 8:58am | 435Read More...Pfizer Inc. (NYSE: PFE)'s acquisition of Medivation Inc (NASDAQ: MDVN) may have come as a surprise to some, but Pfizer has a long standing history of pursuing large scale M&A deals. With 2016 more than half over, Pfizer has already dished out $5.2 billion to acquire Anacor and $14 billion this...
-
Wedbush Reiterates Outperform and PT of $13 on Anacor Pharmaceuticals
Wednesday, June 29, 2011 - 9:48am | 44Read More...Wedbush reiterated its Outperform rating on Anacor Pharmaceuticals (NASDAQ: ANAC). At the same time, Wedbush left its price target on the company's stock unchanged at $13. In today's trading, Anacor lost 3.04% of its values to trade around $6.37.
